RN7SL343P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RN7SL343P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RN7SL343P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL343P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL343P expression acts as an unfavorable survival marker.

LUSC and PAAD are the cancer types where RN7SL343P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUSCOSTertileAll0.2200.777<.00199view →
PAADOSTertileII,III,IV0.1630.589<.00163view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RN7SL343P–LUSC (OS)

Kaplan–Meier survival curve for RN7SL343P RNA-high vs -low samples in LUSC.

Open the LUSC breakdown →

Exploration